In the past, atherosclerosis was largely defined in terms of the accumulation of plaque or bad cholesterol (LDL) within the arterial walls, leading to obstructions. However, it is now understood to be more than a simple build-up of plaque.
This obstruction is actually a physical response to injuries in the walls’ lining. Causes of arterial wall injuries include high blood pressure, infectious microbes, or excessive presence of a certain amino acid called homocysteine. Studies have demonstrated that inflammatory molecules stimulate events leading to the development of atherosclerotic lesions.
Some researchers consider atherosclerosis a natural type of band-aid approach to cover an injury or inflammation. When the band-aid becomes too thick or breaks loose, symptoms of a chronic or acute nature occur. In mild cases, this can lead to diminished oxygen supply to the tissue on the other side of the occlusion; in acute cases, it can cause severe strokes or heart attacks.
Rated 1.6 / 5 (How Ratings Work)
Possibility of efficacy for cannabis in treatment of atherosclerosis.
Based on 8 Studies from 2006 - 2017
Study Name, Description & Year
Rating
Inhibitory Effect Of Trans-caryophyllene (TC) On Leukocyte-endothelial Attachment
Laboratory Study — 2017
Activation Of GPR55 Receptors Exacerbates OxLDL-Induced Lipid Accumulation And Inflammatory Responses, While Reducing Cholesterol Efflux From Human Macrophages
Laboratory Study — 2015
Cannabidiol As An Emergent Therapeutic Strategy For Lessening The Impact Of Inflammation On Oxidative Stress
Review — 2011
Activation Of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression Of Adhesion Molecules
Animal study — 2010
Cannabidiol-2',6'-dimethyl Ether, A Cannabidiol Derivative, Is A Highly Potent And Selective 15-lipoxygenase Inhibitor
Laboratory — 2009
Beta-caryophyllene Is A Dietary Cannabinoid
Animal study (mice) — 2008
The Cannabinergic System As A Target For Anti-inflammatory Therapies
Laboratory — 2006
The Cannabinergic System As A Target For Anti-inflammatory Therapies
Animal study — 2006